Platelet adhesion assay for evaluation of anti-platelet treatment in coronary heart disease
- Conditions
- Coronary heart disease, angina pectoris
- Registration Number
- EUCTR2005-003927-38-SE
- Lead Sponsor
- Per Whiss, Faculty of Health Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Authorised-recruitment may be ongoing or finished
- Sex
- All
- Target Recruitment
- 30
Consecutive patients, 40-70 years, at the Heartrehabilitation unit, University hospital in Linköping, Sweden which have earlier been diagnosed as instable angina or have been treated with percutaneous coronary intervention (PCI) and are treated with Trombyl + Plavix.
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years)
F.1.3.1 Number of subjects for this age range
- Insulin treated diabetes
- Immunological or malignant disease
- Acute liver disease or increased liver enzymes in plasma (>20 % of reference)
- Renal disease or S-kreatinin >150 umol/L
- Heart insufficiency NYHA class III-IV
- Hemodynamic important heart valve defect
- Treatment with antibiotics, immunosuppressive, including corticosteroids, or continous NSAID intake (not ioncluding low dose ASA)
- Thoracal epidural anesthesia caused by severe angina
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method